Strategies to improve migraine treatment results

Drugs

Volumn 66, Issue SUPPL. 3, 2006, Pages 9-16

  Lucas, Christian ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALMOTRIPTAN; ANALGESIC AGENT; ELETRIPTAN; METOCLOPRAMIDE; NARATRIPTAN; NONSTEROID ANTIINFLAMMATORY AGENT; PLACEBO; RIZATRIPTAN; SUMATRIPTAN; ZOLMITRIPTAN;

ANALGESIA; CLINICAL TRIAL; DISABILITY; DISEASE SEVERITY; HUMAN; META ANALYSIS; MIGRAINE; PAIN ASSESSMENT; PATIENT CARE; PATIENT SATISFACTION; PRACTICE GUIDELINE; RECURRENT DISEASE; REVIEW; STRATEGIC PLANNING; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 33751521601     PISSN: 00126667     EISSN: 00126667     Source Type: Journal    
DOI: 10.2165/00003495-200666003-00003     Document Type: Review

References (35)

1. Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 2000; 60: 1259-87
2. (1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001; 358: 1668-75
3. Tfelt-Hansen P, Block G, Dahlöf C, et al. Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 2000; 20: 765-86
4. Geraud G, Lanteri-Minet M, Lucas C, et al. French guidelines for the diagnosis and management of migraine in adults and children. Clin Ther 2004; 26: 1305-18
5. Lainez M. Clinical benefits of early triptan therapy for migraine. Cephalalgia 2004; 24 (suppl 2): 24-30
6. Lipton RB, Stewart WF. Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache 1999; 39 (suppl 2): S20-6
7. Davies GM, Santanello N, Lipton R. Determinants of patient satisfaction with migraine therapy. Cephalalgia 2000; 20: 554-60
8. Sandrini G, Dahlof CG, Mathew N, et al. Focus on trial endpoints of clinical relevance and the use of almotriptan for the acute treatment of migraine. Int J Clin Pract 2005; 59: 1356-65
9. Lipton RB. Disability assessment as a basis for stratified care. Cephalalgia 1998; 18 (suppl 22): 40-3
10. Lipton RB, Stewart WF, Stone AM, et al. Stratified care vs step care strategies for migraine: the Disability in Strategies of Care (DISC) study: a randomized trial. JAMA 2000; 284: 2599-605
11. Williams P, Dowson AJ, Rapoport AM, et al. The cost effectiveness of stratified care in the management of migraine. Pharmacoeconomics 2001; 19: 819-29
12. Lipton RB, Scher AI, Steiner TJ, et al. Patterns of health care utilization for migraine in England and in the United States. Neurology 2003; 60: 441-8
13. Lucas C, Chauffaut C, Artaz MA, et al. FRAMIG 2000; medical and therapeutic management of migraine in France. Cephalalgia 2004; 25: 267-79
14. Unger J, Cady RK, Farmer-Cady K. Understanging migraine: pathophysiology and presentation. Available at: http://www.emedmag.com/html/pre/cov/covers/ 081503:asp. Accessed: 10 November 2005.
15. Adelman JU, Adelman LC, Freeman MC, et al. Cost considerations of acute migraine treatment. Headache 2004; 44: 271-85
16. Sculpher M, Millson D, Meddis D, et al. Cost-effectiveness analysis of stratified versus stepped care strategies for acute treatment of migraine: the Disability in Strategies for Care (DISC) study. Pharmacoeconomics 2002; 20: 91-100
17. 1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia 2002; 22: 633-58
18. Dowson A, Mathew N, Pascual J. Review of clinical trials using early acute intervention with oral triptans for migraine management. Int J Clin Pract 2006; 60: 698-706
19. Cady RK, Sheftell F, Lipton RB, et al. Effect of early intervention with sumatriptan on migraine pain: retrospective analyses of data from three clinical trials. Clin Ther 2000; 22: 1035-48
20. Brandes J, Kudrow D, Cady R, et al. Eletriptan in the early treatment of acute migraine: influence of pain intensity and time of dosing. Cephalalgia 2005; 25: 735-42
21. Mathew NT. Early intervention with almotriptan improves sustained pain-free response in acute migraine. Headache 2003; 43: 1075-9
22. Pascual J, Cabarrocas X. Within-patient early versus delayed treatment of migraine attacks with almotriptan: the sooner the better. Headache 2002; 42: 28-31
23. Dowson AJ, Massiou H, Lainez JM, et al. Almotriptan improves response rates when treatment is within 1 hour of migraine onset. Headache 2004; 44: 318-22
24. Scholpp J, Schellenberg R, Moeckesch B, et al. Early treatment of a migraine attack while pain is still mild increases the efficacy of sumatriptan. Cephalalgia 2004; 24: 925-33
25. Klapper J, Lucas C, Rosjo O, et al. Benefits of treating highly disabled migraine patients with zolmitriptan while pain is mild. Cephalalgia 2004; 24: 918-24
26. Winner P, Mannix LK, Putnam DG, et al. Pain-free results with sumatriptan taken at the first sign of migraine pain: 2 randomized, double-blind, placebo-controlled studies. Mayo Clin Proc 2003; 78: 1214-22
27. Mathew NT, Kailasam J, Meadors L. Early treatment of migraine with rizatriptan: a placebo-controlled study. Headache 2004; 44: 669-73
28. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack: clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain 2000; 123: 1703-9
29. Burstein R. Deconstructing migraine headache into peripheral and central sensitization. Pain 2001; 89: 107-10
30. Burstein R, Collins B, Jakubowski M. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia. Ann Neurol 2004; 55: 19-26
31. Cady R, Martin V, Mauskop A, et al. Symptoms of cutaneous sensitivity pretreatment and post-treatment: results from the rizatriptan TAME study. Cephalalgia 2005; 25: 860
32. Cady RK, Mathew NT, Mao L, et al. Allodynia-associated symptoms, pain intensity and migraine-associated symptoms in early intervention. Headache 2006; 46: 861-2
33. Lipton RB, Stewart WF, Cady R, et al. 2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study. Headache 2000; 40: 783-91
34. Halpern MT, Lipton RB, Cady RK, et al. Costs and outcomes of early versus delayed migraine treatment with sumatriptan. Headache 2002; 42: 984-99
35. Gallagher RM, Kunkel R. Migraine medication attributes important for patient compliance: Concerns about side effects may delay treatment. Headache 2003; 43: 36-44